COVID-19 AND BEYOND
COVID-19 has demonstrated the need for rapid responses, widely accessible testing, and contact tracing. This same response is required annually for the flu, SARS, MRSA, and other communicable diseases. The technology that powers Veralize can be quickly adapted to detect any strain of virus or bacterial infection. Shortening the testing cycle saves lives and reduces cost to the increasingly strained healthcare system.